Research And Development
Health
Therapy

Kitov Pharmaceuticals

$1.16
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.02 (-1.69%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell KTOV and other stocks, options, ETFs, and crypto commission-free!

About

Kitov Pharma Ltd. American Depositary Shares, also called Kitov Pharmaceuticals, is a development stage biopharmaceutical company, which engages in drug development. Read More The firm offers Consensi and NT219. Consensi is intended to treat osteoarthritis pain and hyper tension simultaneously, while NT219 is a cancer therapy drug that delivers anti-tumor effects and increasing survical in various cancer models. The company was founded by John Paul Waymack in June 2010 and is headquartered in Tel Aviv, Israel.

Employees
10
Headquarters
Tel Aviv, Tel Aviv
Founded
2010
Market Cap
853.70K
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
736.95K
High Today
$1.20
Low Today
$1.14
Open Price
$1.16
Volume
120.41K
52 Week High
$3.81
52 Week Low
$0.56

Collections

Research And Development
Health
Therapy
Medical
Pharmaceutical
Technology
2015 IPO
US
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.